Midwest Capital Advisors’s Pfizer PFE Stock Holding History

Midwest Capital Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.17K	Hold	90	–	–	﹤0.01%	191
2026 Q1	$2.53K	Sell	90 -17	-16%	-$453	﹤0.01%	183
2025 Q4	$2.67K	Hold	107	–	–	﹤0.01%	175
2025 Q3	$2.73K	Hold	107	–	–	﹤0.01%	184
2025 Q2	$2.59K	Sell	107 -17	-14%	-$396	﹤0.01%	172
2025 Q1	$3.13K	Buy	124 +1	+0.8%	+$26	﹤0.01%	171
2024 Q4	$3.27K	Buy	+123	New	+$3.34K	﹤0.01%	179

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Midwest Capital Advisors's PFE Position: Q2 2026 in Review

Midwest Capital Advisors held its Pfizer (PFE) position steady in Q2 2026 at 90 shares worth $2.17K. The position accounts for ﹤0.01% of the portfolio, ranked #191.

Midwest Capital Advisors first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.27K in Q4 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Midwest Capital Advisors held 90 shares of Pfizer worth $2.17K as of Q2 2026.
Midwest Capital Advisors left its Pfizer share count unchanged in Q2 2026.
Pfizer made up ﹤0.01% of Midwest Capital Advisors's portfolio in Q2 2026, its #191 holding.
Midwest Capital Advisors first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
Midwest Capital Advisors's Pfizer position peaked at $3.27K in Q4 2024.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Midwest Capital Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.